ImmuneOncia's Corporate Minority Round

ImmuneOncia raised a round of funding on March 02, 2016. Investors include Sorrento Therapeutics.

ImmuneOncia was created to develop and commercialize a number of immune checkpoint antibodies against undisclosed targets for both hematological malignancies and solid tumors.…

Articles about ImmuneOncia's Corporate Minority Round: